Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS safety_alert · 2025-05-18Clinical Trial Update: Study of the Safety of MRI Scans in People Who Have Breast Tissue Expanders After Mastectomy
This clinical trial update provides information on the safety of performing MRI scans in people who have breast tissue expanders after maste…
-
EMA safety_alert · 2020-10-01EMA reminds physicians to use Tecentriq with nab-paclitaxel for treating breast cancer
EMA reminds physicians to use Tecentriq (atezolizumab) in combination with nab-paclitaxel for treating certain breast cancer indications, hi…
-
EMA safety_alert · 2017-06-09PRAC concludes there is no evidence of a change in known risk of neutropenic enterocolitis with docetaxel
The EMA's Pharmacovigilance Risk Assessment Committee (PRAC) concluded there is no evidence of a change in the known risk of neutropenic ent…
-
CLINICAL_TRIALS safety_alert · 2017-04-07Clinical Trial Update: Emergence of Chemotherapy Related Hyperglycemia in nOn-diabetic Patients
A clinical trial update reports chemotherapy-related hyperglycemia in non-diabetic patients. The finding involves cancers including colorect…
-
CLINICAL_TRIALS safety_alert · 2015-04-15Clinical Trial Update: Physician Liver Function Test (LFT) Monitoring for Tykerb Pts
An update outlining liver function test (LFT) monitoring requirements for patients treated with Tykerb (lapatinib) in cancer trials. It emph…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS safety_alert · 2014-05-02Clinical Trial Update: Cardiotoxicity in Metastatic Her 2 Positive Patients Treated With Trastuzumab ,Pertuzumab and Taxanes
A clinical trial update highlights concerns about cardiotoxicity in metastatic HER2-positive breast cancer patients treated with trastuzumab…
-
EMA safety_alert · 2014-04-17European Medicines Agency update on stolen vials of Herceptin
EMA reports stolen vials of Herceptin and provides information to healthcare professionals and the public on continuing safety and supply co…
-
EMA safety_alert · 2014-04-16European Medicines Agency alerts EU healthcare professionals after vials of falsified Herceptin identified
The European Medicines Agency alerted healthcare professionals in the EU after identifying vials of falsified Herceptin, emphasizing precaut…
-
EMA safety_alert · 2009-01-22European Medicines Agency recommends new contraindication for Fareston (toremifene)
The EMA recommended a new contraindication for Fareston (toremifene), highlighting situations where the drug should not be used due to safet…
-
EMA safety_alert · 2006-11-22Defect in Herceptin vials identified but supply for patients is maintained
A defect was identified in Herceptin vials, but supply for patients is maintained.